These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. xCT modulation in gliomas: relevance to energy metabolism and tumor microenvironment normalization. Savaskan NE; Eyüpoglu IY Ann Anat; 2010 Sep; 192(5):309-13. PubMed ID: 20801625 [TBL] [Abstract][Full Text] [Related]
3. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Huang Y; Dai Z; Barbacioru C; Sadée W Cancer Res; 2005 Aug; 65(16):7446-54. PubMed ID: 16103098 [TBL] [Abstract][Full Text] [Related]
4. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/beta-catenin pathway. Chen RS; Song YM; Zhou ZY; Tong T; Li Y; Fu M; Guo XL; Dong LJ; He X; Qiao HX; Zhan QM; Li W Oncogene; 2009 Jan; 28(4):599-609. PubMed ID: 19015640 [TBL] [Abstract][Full Text] [Related]
5. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma. Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978 [TBL] [Abstract][Full Text] [Related]
6. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234 [TBL] [Abstract][Full Text] [Related]
7. Decreased expression of the active subunit of the cystine/glutamate antiporter xCT is associated with loss of heterozygosity of 1p in oligodendroglial tumours WHO grade II. Stockhammer F; von Deimling A; van Landeghem FK Histopathology; 2009 Jan; 54(2):241-7. PubMed ID: 19207949 [TBL] [Abstract][Full Text] [Related]
8. Histone deacetylases inhibition by SAHA/Vorinostat normalizes the glioma microenvironment via xCT equilibration. Wolf IM; Fan Z; Rauh M; Seufert S; Hore N; Buchfelder M; Savaskan NE; Eyüpoglu IY Sci Rep; 2014 Sep; 4():6226. PubMed ID: 25228443 [TBL] [Abstract][Full Text] [Related]
9. Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin. Belkaid A; Copland IB; Massillon D; Annabi B FEBS Lett; 2006 Jun; 580(15):3746-52. PubMed ID: 16777101 [TBL] [Abstract][Full Text] [Related]
10. Distribution of the cystine/glutamate antiporter system xc- in the brain, kidney, and duodenum. Burdo J; Dargusch R; Schubert D J Histochem Cytochem; 2006 May; 54(5):549-57. PubMed ID: 16399997 [TBL] [Abstract][Full Text] [Related]
11. Burn injury induces the expression of cystine/glutamate transporter (x(c)(-)) in mouse T cells. D'Elia M; Patenaude J; Dupras C; Bernier J Immunol Lett; 2009 Aug; 125(2):137-44. PubMed ID: 19576933 [TBL] [Abstract][Full Text] [Related]
12. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Chen D; Fan Z; Rauh M; Buchfelder M; Eyupoglu IY; Savaskan N Oncogene; 2017 Oct; 36(40):5593-5608. PubMed ID: 28553953 [TBL] [Abstract][Full Text] [Related]
13. Actinomycin D inhibits the expression of the cystine/glutamate transporter xCT via attenuation of CD133 synthesis in CD133 Song Y; Park IS; Kim J; Seo HR Chem Biol Interact; 2019 Aug; 309():108713. PubMed ID: 31226288 [TBL] [Abstract][Full Text] [Related]
14. Cystine-glutamate transporter SLC7A11 mediates resistance to geldanamycin but not to 17-(allylamino)-17-demethoxygeldanamycin. Liu R; Blower PE; Pham AN; Fang J; Dai Z; Wise C; Green B; Teitel CH; Ning B; Ling W; Lyn-Cook BD; Kadlubar FF; Sadée W; Huang Y Mol Pharmacol; 2007 Dec; 72(6):1637-46. PubMed ID: 17875604 [TBL] [Abstract][Full Text] [Related]
15. Expression and function of cystine/glutamate transporter in neutrophils. Sakakura Y; Sato H; Shiiya A; Tamba M; Sagara J; Matsuda M; Okamura N; Makino N; Bannai S J Leukoc Biol; 2007 Apr; 81(4):974-82. PubMed ID: 17200146 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of cell proliferation in neurogenic zones in mice lacking cystine transport by xCT. Liu RR; Brown CE; Murphy TH Biochem Biophys Res Commun; 2007 Dec; 364(3):528-33. PubMed ID: 17963724 [TBL] [Abstract][Full Text] [Related]
17. Regulation of xCT expression and system x (c) (-) function in neuronal cells. Lewerenz J; Maher P; Methner A Amino Acids; 2012 Jan; 42(1):171-9. PubMed ID: 21369940 [TBL] [Abstract][Full Text] [Related]
18. Gamma-tocopheryl quinone, not alpha-tocopheryl quinone, induces adaptive response through up-regulation of cellular glutathione and cysteine availability via activation of ATF4. Ogawa Y; Saito Y; Nishio K; Yoshida Y; Ashida H; Niki E Free Radic Res; 2008 Jul; 42(7):674-87. PubMed ID: 18654882 [TBL] [Abstract][Full Text] [Related]
19. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Sehm T; Fan Z; Ghoochani A; Rauh M; Engelhorn T; Minakaki G; Dörfler A; Klucken J; Buchfelder M; Eyüpoglu IY; Savaskan N Oncotarget; 2016 Jun; 7(24):36021-36033. PubMed ID: 27074570 [TBL] [Abstract][Full Text] [Related]
20. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Robert SM; Buckingham SC; Campbell SL; Robel S; Holt KT; Ogunrinu-Babarinde T; Warren PP; White DM; Reid MA; Eschbacher JM; Berens ME; Lahti AC; Nabors LB; Sontheimer H Sci Transl Med; 2015 May; 7(289):289ra86. PubMed ID: 26019222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]